Showing 14,261 - 14,280 results of 41,669 for search '(( 50 ((we decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( a point decrease ))', query time: 0.94s Refine Results
  1. 14261
  2. 14262

    Heparinase treatment ablated daily oscillations in Aβ42 phagocytosis in macrophages. by Gretchen T. Clark (12071965)

    Published 2022
    “…Each cell sampled per time point is represented by a black or gray dot with the mean shown as a red diamond. …”
  3. 14263

    A 15-gene classifier can predict radiation dose levels in mice. by Joseph Lucas (104191)

    Published 2014
    “…While IGH-6 expression decreased in response to irradiation, LOXL1 expression increased promptly and CDKN1A was a late responsive gene.…”
  4. 14264

    A Hypomorphic Lsd1 Allele Results in Heart Development Defects in Mice by Thomas B. Nicholson (406800)

    Published 2013
    “…While there is evidence that Lsd1-interacting proteins regulate the activity and specificity of Lsd1, the significance and roles of such interactions in developmental processes remain largely unknown. Here we describe a hypomorphic Lsd1 allele that contains two point mutations in the tower domain, resulting in a protein with reduced interaction with known binding partners and decreased enzymatic activity. …”
  5. 14265

    The kinetics of the linear component affect the peak frequency of a bell shaped response. by Patrick A. Fletcher (583336)

    Published 2014
    “…(<b>B</b>) The corresponding bell-shaped responses have a peak that shifts to the right accordingly. (<b>C</b>) Duration compensation: increasing τ<sub>a</sub> shifts the response in </a><a><sub>on,∞</sub> and its K crossing point to the right. …”
  6. 14266

    Supplementary file 1_Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in... by Grace Blest-Hopley (10663945)

    Published 2025
    “…</p>Results<p>Improvements were observed across several mental health measures: PTSD (PCL-5 scores decreased by 50%, p=0.010), depression (PHQ-9 scores decreased by 65%, p<0.001), and anxiety (STAI) scores decreased by 28%, p<0.001). …”
  7. 14267

    Supplementary file 2_Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in... by Grace Blest-Hopley (10663945)

    Published 2025
    “…</p>Results<p>Improvements were observed across several mental health measures: PTSD (PCL-5 scores decreased by 50%, p=0.010), depression (PHQ-9 scores decreased by 65%, p<0.001), and anxiety (STAI) scores decreased by 28%, p<0.001). …”
  8. 14268
  9. 14269
  10. 14270

    Image_2_Identification of Sorafenib as a Treatment for Type 1 Diabetes.tif by Qin Zeng (166641)

    Published 2022
    “…Since sorafenib is classified as an FDA-approved drug, it serves as a preliminary lead point for additional experimentation and may be a promising therapy for type 1 diabetes in humans.…”
  11. 14271

    Illustration of three simple scenarios of association between genotype and a bivariate phenotype. by Matthew Stephens (3815)

    Published 2013
    “…A) A variant associated with <i>weight</i> but not <i>height</i>. …”
  12. 14272

    Image_1_Identification of Sorafenib as a Treatment for Type 1 Diabetes.tif by Qin Zeng (166641)

    Published 2022
    “…Since sorafenib is classified as an FDA-approved drug, it serves as a preliminary lead point for additional experimentation and may be a promising therapy for type 1 diabetes in humans.…”
  13. 14273

    Inc exhibits key properties of a Cul3 adaptor in neurons in vivo. by Qiuling Li (390393)

    Published 2025
    “…<p><b>(A)</b> Co-immunoprecipitation of 3×FLAG-Inc and 3×FLAG-3×HA-Cul3 from male whole animal lysates. …”
  14. 14274

    Image_4_Identification of Sorafenib as a Treatment for Type 1 Diabetes.tif by Qin Zeng (166641)

    Published 2022
    “…Since sorafenib is classified as an FDA-approved drug, it serves as a preliminary lead point for additional experimentation and may be a promising therapy for type 1 diabetes in humans.…”
  15. 14275

    Associations between HbA1c levels and mortality and diabetes complications. by Haipeng Ma (6792266)

    Published 2025
    “…The risk increases steadily with increasing HbA1c levels, with no clear inflection point. D: RCS curves for CKD risk. …”
  16. 14276

    Image_6_Identification of Sorafenib as a Treatment for Type 1 Diabetes.tif by Qin Zeng (166641)

    Published 2022
    “…Since sorafenib is classified as an FDA-approved drug, it serves as a preliminary lead point for additional experimentation and may be a promising therapy for type 1 diabetes in humans.…”
  17. 14277

    Image_5_Identification of Sorafenib as a Treatment for Type 1 Diabetes.tif by Qin Zeng (166641)

    Published 2022
    “…Since sorafenib is classified as an FDA-approved drug, it serves as a preliminary lead point for additional experimentation and may be a promising therapy for type 1 diabetes in humans.…”
  18. 14278

    Image_3_Identification of Sorafenib as a Treatment for Type 1 Diabetes.tif by Qin Zeng (166641)

    Published 2022
    “…Since sorafenib is classified as an FDA-approved drug, it serves as a preliminary lead point for additional experimentation and may be a promising therapy for type 1 diabetes in humans.…”
  19. 14279

    RAINFALL REGIME ON FINE ROOT GROWTH IN A SEASONALLY DRY TROPICAL FOREST by EUNICE MAIA DE ANDRADE (4894216)

    Published 2021
    “…The fine root biomass in July 2015 was 7.7±5.0 Mg ha-1 and the length was 5.0±3.2 km m-2. Fine root growth in SDTF is strongly limited by dry periods, occurring decreases in biomass and length of fine roots in all layers evaluated. …”
  20. 14280